Its essential to discuss all your medications with your provider to identify any potential interactions
Class-wide precautions for GLP-1-based agents include a possible increased risk of pancreatitis, gallbladder issues, and based on rodent studies a boxed warning regarding medullary thyroid carcinoma, meaning it is contraindicated in people with a personal or family history of that cancer or of multiple endocrine neoplasia type 2
As it is not fully approved, most of what we know about its safety and side effects emerges from ongoing and recent clinical trials
GLP-1 receptor agonists such as brand-named drugs Wegovy and Zepbound have been game changers for lots of people looking to lose weight
It isnt the same as Rybelsus, which is a lower-dose semaglutide tablet licensed for type 2 diabetes
If you or a loved one experienced significant complications after taking Wegovy or a similar medication, it may be important to understand whether you have a potential claim
